Biopharmaceutical company, Sanofi, has completed the acquisition of Translate Bio, an mRNA therapeutics company developing medicines to treat diseases caused by protein or gene dysfunction. The acquisition, announced in August,…
Biopharmaceutical company, Sanofi, has completed the acquisition of Translate Bio, an mRNA therapeutics company developing medicines to treat diseases caused by protein or gene dysfunction. The acquisition, announced in August,…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference

